Corpus Intelligence IC Memo — PAUL B. HALL REGIONAL MEDICAL CENTER 2026-04-26 14:09 UTC
IC Memo — PAUL B. HALL REGIONAL MEDICAL CENTER
Investment Committee Memorandum | KY | 72 beds | Grade C | EBITDA uplift $466K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PAUL B. HALL REGIONAL MEDICAL CENTER

CCN 180078 | JOHNSON, KY | 72 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PAUL B. HALL REGIONAL MEDICAL CENTER is a 72-bed suburban community hospital in JOHNSON, KY with $6.2M in net patient revenue and a 10.3% operating margin. The hospital serves a payer mix of 30.5% Medicare, 4.1% Medicaid, and 65.4% commercial.

Thesis: Turnaround. Our ML models identify $466K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.3% to 17.8% (+753bps).

Net Revenue HCRIS$6.2M
Current EBITDA COMPUTED$634K
Operating Margin COMPUTED10.3%
Occupancy HCRIS25.3%
Revenue / Bed COMPUTED$86K
Net-to-Gross HCRIS9.1%
Distress Probability ML53.2%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
49
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 10.3% places it above the state median. Among 49 size-comparable peers (36-144 beds), the median margin is 0.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-144), prioritizing same-state peers. 49 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PAUL B. HALL REGIONAL MEDICAL (Target)KY72$6.2M10.3%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
ST. CLAIRE MEDICAL CENTERKY100$204.5M-8.5%
HAZARD ARHKY109$200.8M-32.3%
T.J. SAMSON COMMUNITY HOSPITALKY112$189.4M-10.5%
SAINT JOSEPH LONDONKY118$173.7M-8.1%
JENNIE STUART MEDICAL CENTERKY122$165.3M-6.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $466K (753bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$130K+210bp18mo
Denial Rate Reduction12.0%6.5%$127K+206bp12mo
Cost to Collect4.5%2.5%$124K+200bp12mo
A/R Days Reduction5200.0%3800.0%$75K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+16bp6mo

5. EBITDA Bridge

Net Collection Rate
$130K
Denial Rate Reduction
$127K
Cost to Collect
$124K
A/R Days Reduction
$75K
Clean Claim Rate
$10K
Total EBITDA Uplift$466K
Current EBITDA$634K
+ RCM Uplift+$466K
Pro Forma EBITDA$1.1M
Current Margin10.3%
Pro Forma Margin17.8%
WC Released (1x)$237K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$976K$8.8M9.06x55.4%
Base (11x exit)10.0x11.0x$976K$10.0M10.29x59.4%
Bull Case9.0x11.0x$878K$11.9M13.54x68.4%
Bull (12x exit)9.0x12.0x$878K$13.2M15.07x72.0%
Bear Case11.0x10.0x$1.1M$6.2M5.77x42.0%
Bear (11x exit)11.0x11.0x$1.1M$7.2M6.67x46.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 25.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 53.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 49 hospitals with 36-144 beds
  • Same-state prioritization (n=50)
  • Comp margins: P25=-10.5% / P50=0.1% / P75=10.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.